Skip to main content

Day: July 29, 2025

VERSES® Shareholder Update Letter

Webinar to Follow at 9:30am PT/12:30pm ET Today VANCOUVER, British Columbia, July 29, 2025 (GLOBE NEWSWIRE) — VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) (“VERSES” or the “Company”), a cognitive computing company specializing in next-generation agentic software systems releases a shareholder letter ahead of the corporate webinar today, Tuesday June 29th at 9:30am PT/12:30pm ET. Shareholder Update Summer 2025 Thank you to all of our investors and stakeholders who have supported us during the last few years, and especially during the most recent challenging times. We are hosting a webinar today and look forward to discussing these points in more detail and we encourage you to join us using this link: Here We are at day 1 of AI When we founded VERSES we were excited by the possibilities that AI and Spatial Computing...

Continue reading

Eagle Bancorp Montana Earns $3.2 Million, or $0.41 per Diluted Share, in the Second Quarter of 2025; Increases Quarterly Cash Dividend to $0.145 Per Share

HELENA, Mont., July 29, 2025 (GLOBE NEWSWIRE) — Eagle Bancorp Montana, Inc. (NASDAQ: EBMT), (the “Company,” “Eagle”), the holding company of Opportunity Bank of Montana (the “Bank”), today reported net income of $3.2 million, or $0.41 per diluted share, in the second quarter of 2025, compared to $3.2 million, or $0.41 per diluted share, in the preceding quarter, and $1.7 million, or $0.22 per diluted share, in the second quarter of 2024. In the first six months of 2025, net income increased to $6.5 million, or $0.83 per diluted share, compared to $3.6 million, or $0.46 per diluted share, in the first six months of 2024. Eagle’s board of directors declared a quarterly cash dividend of $0.145 per share on July 24, 2025. The dividend will be payable September 5, 2025, to shareholders of record August 15, 2025. The current dividend...

Continue reading

Form 8.3 – [MARLOWE PLC – 28 07 2025] – (CGWL)

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)   Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b)   Owner or controller of interests and short positions disclosed, if different from 1(a):        The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)   Name of offeror/offeree in relation to whose relevant securities this form relates:        Use a separate form for each offeror/offeree MARLOWE PLC(d)   If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e)   Date position held/dealing...

Continue reading

BioPorto A/S to host an investor webcast on the results for the first half of 2025

   July 29, 2025 News release BioPorto A/S to host an investor webcast on the results for the first half of 2025 COPENHAGEN, DENMARK, July 29, 2025 (GLOBE NEWSWIRE) – BioPorto A/S (BioPorto or the Company) (CPH:BIOPOR), announced today that CFO Niels Høy Nielsen will present financial results for the first half of 2025 at a webcast for investors on August 15 at 11:00 AM CET. Registration for the presentation is now open, and participants can submit questions in advance. Please register at the following link: https://www.inderes.dk/videos/bioporto-praesentation-af-halvarsregnskabet-for-2025 For further information, please contact: Hanne S. Foss, Head of Investor Relations, BioPorto A/S, investor@bioporto.com, C: +45 26368918  About BioPorto BioPorto is an in vitro diagnostics company focused on saving lives and improving the quality of...

Continue reading

NewGen Announces Strategic Acquisition of Cytometry Technology and Assets to Support Planned U.S. Expansion

The new cytometry technology enhances accessibility, safety, and efficiency in sperm-sorting procedures The acquisition of 18 cell-sorting systems and associated patents positions NewGen for U.S. expansion, where over 430,000 IVF cycles took place in 2023 BANGKOK, July 29, 2025 (GLOBE NEWSWIRE) — NewGenIvf Group Limited (NASDAQ: NIVF) (“NewGen” or the “Company”), a comprehensive fertility services provider in Asia helping couples and individuals obtain access to fertility treatments, today announced that it has acquired cytometry technology and assets including 18 fully-constructed cell-sorting and dispensing systems, eight partially constructed units, and six patents related to advanced microfluidic systems. This acquisition of physical machinery, intellectual property, and manufacturing know-how provides the Company with cutting-edge...

Continue reading

Summit State Bank Earns $2.4 Million, or $0.36 Per Diluted Share, in Second Quarter 2025

SANTA ROSA, Calif., July 29, 2025 (GLOBE NEWSWIRE) — Summit State Bank (the “Bank”) (Nasdaq: SSBI) today reported net income of $2,417,000, or $0.36 per diluted share for the second quarter ended June 30, 2025, compared to net income of $928,000, or $0.14 per diluted share for the second quarter ended June 30, 2024. “We delivered strong operating results in the second quarter of 2025 – our second consecutive quarter of solid earnings – driven by robust net interest income and meaningful margin expansion,” said Brian Reed, President and CEO. “With notable progress made in addressing problem loans that weighed on 2024 results, we are encouraged by the momentum in our earnings outlook. Despite ongoing market volatility in the broader financial sector, we remain disciplined in our balance sheet strategy and operational execution....

Continue reading

First Pacific Bancorp Reports Strong Second Quarter 2025 Results

WHITTIER, Calif., July 29, 2025 (GLOBE NEWSWIRE) — First Pacific Bancorp (the “Company”) (OTCID: FPBC), the holding company for First Pacific Bank (the “Bank”), today reported consolidated results for the second quarter ending June 30, 2025. The Company remains well-capitalized, with a healthy liquidity position supported by a stable core deposit base and access to substantial sources of liquidity. Highlights for the second quarter of 2025 include:Total assets ended the second quarter of 2025 at $478 million, up $45 million since year end 2024. Total deposits ended the second quarter of 2025 at $378 million, up $27 million since year end 2024. Total loans ended the second quarter of 2025 at $312 million, up $35 million from year end 2024. Asset quality remains excellent with minimal levels of classified or non-performing assets. The...

Continue reading

ScanTech AI Unlocks Potential $100M Market Opportunity Through TIPS Procurement Contract with Creeksource Consulting

New Procurement Pathway Enhances Access to ScanTech AI Solutions for Public Sector Agencies Nationwide Through TIPS Cooperative Atlanta, GA, July 29, 2025 (GLOBE NEWSWIRE) — ScanTech AI Systems Inc. (the “Company” or “ScanTech AI”) (Nasdaq: STAI),  a leading innovator in advanced security screening technologies, announced today it will offer its technologies through an The Interlocal Purchasing System (TIPS) contract that it entered into with Creeksource Consulting LLC. This enables eligible government entities, educational institutions, municipalities, and nonprofits to potentially purchase ScanTech AI’s solutions via the TIPS national purchasing cooperative. Through the Teaming Agreement with Creeksource, an approved TIPS vendor, ScanTech AI aims to streamline procurement, minimize administrative burden,...

Continue reading

AEHL Signs $50 Million Strategic Financing Agreement to Launch Bitcoin Acquisition Plan

New York, USA, July 29, 2025 (GLOBE NEWSWIRE) — Antelope Enterprise Holdings Limited (NASDAQ:AEHL) (“Antelope Enterprise”, “AEHL” or the “Company”) today announced that it has entered into a Securities Purchase Agreement (the “Agreement”) with a leading U.S.-based investment firm, Streeterville Capital, LLC, for a total financing amount of up to $50 million. The proceeds from this financing will be used exclusively to purchase Bitcoin (BTC), marking a major step forward in AEHL’s entry into the cryptocurrency asset space. Under the terms of the Agreement, Streeterville Capital will provide capital to the Company in tranches over a period of up to 24 months, in an amount not to exceed $50 million. AEHL will use these funds to gradually acquire Bitcoin based on market conditions. The Agreement clearly specifies that the financing...

Continue reading

Akari Therapeutics Releases Virtual Investor “What This Means” Segment

Abizer Gaslightwala, President and CEO of Akari Therapeutics discussed Akari’s commitment to continued research to better understand the multiple effects of its novel spliceosome modulator, PH1 Watch the “What This Means” video here BOSTON and LONDON, July 29, 2025 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing novel immuno-oncology payload antibody drug conjugates (ADCs) for the treatment of cancer, today announced that Abizer Gaslightwala, President and CEO of Akari Therapeutics participated in a Virtual Investor “What This Means” segment. As part of the segment, Mr. Gaslightwala discussed its novel spliceosome modulator payload, PH1, and the Company’s ongoing efforts to build on key data for its spliceosome modulator payload with further research ongoing on...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.